Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial

Fig. 4

Time to event curves for the extended net-benefit composite endpoint up to 180 days and to maximal follow up. Illustration of the Kaplan-Meier event curves depicting the cumulative probability of the composite endpoint of cardiovascular (CV) death, cardiogenic shock, rehospitalisation for new myocardial infarct (MI), new hospitalisation for heart failure (HF), definite stent thrombosis (ST), target vessel revascularization (TVR), or stroke up to 180 days (Hazard Ratio (HR) 0.90, 95 % CI (0.79-1.03), P = 0.12) (Panel a) or at maximal follow up (HR 0.91, 95 % CI (0.82-1.01), P = 0.08) (mean 25 months) (Panel b), following percutaneous coronary intervention (PCI) with thrombus aspiration (TA) vs. PCI alone

Back to article page